First Quarter 2021 Revenue Increased 31.2% Year-over-Year with Continued Strong Domestic Growth and Turnaround in International WARSAW, Indiana , May 05, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing

WARSAW, Ind. , April 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey , President, Fred Hite , Chief Operating Officer and Chief

Conference Call to Discuss Results on May 6, 2021 at 8:00 a.m. ET WARSAW, Ind. , April 21, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled

WARSAW, Ind. , March 31, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey , President, Fred Hite , Chief Operating Officer and Chief

The Internal Brace Option™ is a viable alternative for treating progressive moderate scoliosis in adolescents and a game-changing treatment option for medical providers and patients to consider WARSAW, Ind. , March 23, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp.

Full year 2020 revenue of $71.1m compared to full year 2019 revenue of $72.6m , reflecting the impact of COVID-19 on elective surgeries Guidance for full year 2021 sales growth in the range of 31-38%, reaching $93-98 million WARSAW, Ind. , March 10, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp.

WARSAW, Ind. , March 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced that as of March 2021 , it estimates over 200,000 children with orthopedic conditions have been

Conference Call to Discuss Results on March 11, 2021 at 8:00 a.m. ET WARSAW, Ind. , March 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is

WARSAW, Ind. , Feb. 24, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it was recently named as one of the 2021 Best Places to Work in Indiana .

OrthoPediatrics and ApiFix are committed to helping patients with adolescent idiopathic scoliosis and their families make informed decisions about treatment options in partnership with their physiotherapist and pediatric orthopedic specialist WARSAW, Ind. , Feb.

WARSAW, Ind. , Feb. 11, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey , President, Fred Hite , Chief Operating Officer and Chief

WARSAW, Ind. , Jan. 19, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, has obtained 14 product registrations in Canada over the past 12 months.

WARSAW, Ind. , Jan. 15, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its agent network in Germany , Austria and Switzerland .

Full year revenue up 2%, representing strong execution in an unprecedented global environment WARSAW, Ind. , Jan. 11, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics,

WARSAW, Indiana , Jan. 05, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced the 510(k) approval, and limited U.S. launch of its first sterile-packed implants for the Pediatric

WARSAW, Ind. , Jan. 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl , Chief Executive Officer, Fred Hite , Chief Operating Officer